Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPERT-C: Cetuximab with CAPOX and Radiotherapy for Rectal Cancer
NCT00383695Phase 2Unknown
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Sep 2005
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial of cetuximab in rectal cancer, sponsored by Royal Marsden NHS Foundation Trust. Status: unknown.
02
Drugs
cetuximab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00383695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383695.